| Symbol | DXR |
|---|---|
| Name | DAXOR CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 107 MECO LANE, OAK RIDGE, TN 37830 |
| Telephone | 865-425-0555 |
| Fax | — |
| — | |
| Website | https://www.daxor.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000027367 |
| Description | Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. Additional info from NASDAQ: |
New Form 40-17F2 - DAXOR CORP <b>Filed:</b> 2026-05-06 <b>AccNo:</b> 0001493152-26-021450 <b>Size:</b> 82 KB
Read moreDaxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
Read moreDaxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
Read moreDirector Feldschuh Michael Richard 🟢 acquired 1.0K shares of DAXOR CORP (DXR) at $9.07 Transaction Date: Apr 08, 2026 | Filing ID: 016105
Read moreDaxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
Read moreNew Form N-CEN/A - DAXOR CORP <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001493152-26-014857 <b>Size:</b> 23 KB
Read moreNew Form 40-17F2 - DAXOR CORP <b>Filed:</b> 2026-03-31 <b>AccNo:</b> 0001493152-26-014094 <b>Size:</b> 95 KB
Read moreDaxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026
Read moreDaxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026
Read moreJefferies John 🟢 acquired 5.9K shares of DAXOR CORP (DXR) Transaction Date: Mar 20, 2026 | Filing ID: 012444
Read more